TP53 and breast carcinoma: However, mechanisms that mediate the overexpression of MDM4 in breast cancer have not been identified, and factors capable of regulating MDM4 gene expression in human cells remain largely unknown, with only two main pathways having been identified to date: p53 and mitogen-activated protein kinase (MAPK) [35, 73].